157 related articles for article (PubMed ID: 35299662)
21. Oleoylethanolamide Increases Glycogen Synthesis and Inhibits Hepatic Gluconeogenesis via the LKB1/AMPK Pathway in Type 2 Diabetic Model.
Ren T; Ma A; Zhuo R; Zhang H; Peng L; Jin X; Yao E; Yang L
J Pharmacol Exp Ther; 2020 Apr; 373(1):81-91. PubMed ID: 32024803
[TBL] [Abstract][Full Text] [Related]
22. Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP.
Kim YD; Park KG; Lee YS; Park YY; Kim DK; Nedumaran B; Jang WG; Cho WJ; Ha J; Lee IK; Lee CH; Choi HS
Diabetes; 2008 Feb; 57(2):306-14. PubMed ID: 17909097
[TBL] [Abstract][Full Text] [Related]
23. Involvement of AMPK activation in the inhibition of hepatic gluconeogenesis by Ficus carica leaf extract in diabetic mice and HepG2 cells.
Zhang Y; Chen J; Zeng Y; Huang D; Xu Q
Biomed Pharmacother; 2019 Jan; 109():188-194. PubMed ID: 30396076
[TBL] [Abstract][Full Text] [Related]
24. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
Wei S; Li W; Yu Y; Yao F; A L; Lan X; Guan F; Zhang M; Chen L
Life Sci; 2015 Oct; 139():8-15. PubMed ID: 26285176
[TBL] [Abstract][Full Text] [Related]
25. AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner.
Lee JM; Seo WY; Song KH; Chanda D; Kim YD; Kim DK; Lee MW; Ryu D; Kim YH; Noh JR; Lee CH; Chiang JY; Koo SH; Choi HS
J Biol Chem; 2010 Oct; 285(42):32182-91. PubMed ID: 20688914
[TBL] [Abstract][Full Text] [Related]
26. Follicle-stimulating hormone enhances hepatic gluconeogenesis by GRK2-mediated AMPK hyperphosphorylation at Ser485 in mice.
Qi X; Guo Y; Song Y; Yu C; Zhao L; Fang L; Kong D; Zhao J; Gao L
Diabetologia; 2018 May; 61(5):1180-1192. PubMed ID: 29442133
[TBL] [Abstract][Full Text] [Related]
27. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B
J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053
[TBL] [Abstract][Full Text] [Related]
28. Endoplasmic reticulum stress-induced activation of activating transcription factor 6 decreases cAMP-stimulated hepatic gluconeogenesis via inhibition of CREB.
Seo HY; Kim MK; Min AK; Kim HS; Ryu SY; Kim NK; Lee KM; Kim HJ; Choi HS; Lee KU; Park KG; Lee IK
Endocrinology; 2010 Feb; 151(2):561-8. PubMed ID: 20022930
[TBL] [Abstract][Full Text] [Related]
29. Empagliflozin protects heart from inflammation and energy depletion via AMPK activation.
Koyani CN; Plastira I; Sourij H; Hallström S; Schmidt A; Rainer PP; Bugger H; Frank S; Malle E; von Lewinski D
Pharmacol Res; 2020 Aug; 158():104870. PubMed ID: 32434052
[TBL] [Abstract][Full Text] [Related]
30. Exogenous administration of DLK1 ameliorates hepatic steatosis and regulates gluconeogenesis via activation of AMPK.
Lee YH; Yun MR; Kim HM; Jeon BH; Park BC; Lee BW; Kang ES; Lee HC; Park YW; Cha BS
Int J Obes (Lond); 2016 Feb; 40(2):356-65. PubMed ID: 26315841
[TBL] [Abstract][Full Text] [Related]
31. Empagliflozin Induces White Adipocyte Browning and Modulates Mitochondrial Dynamics in KK Cg-Ay/J Mice and Mouse Adipocytes.
Xu L; Xu C; Liu X; Li X; Li T; Yu X; Xue M; Yang J; Kosmas CE; Moris D; Sanchis-Gomar F; Yoshida N; Berger NA; Aronow WS; Sun B; Chen L
Front Physiol; 2021; 12():745058. PubMed ID: 34777009
[No Abstract] [Full Text] [Related]
32. Ferulic acid exerts its antidiabetic effect by modulating insulin-signalling molecules in the liver of high-fat diet and fructose-induced type-2 diabetic adult male rat.
Narasimhan A; Chinnaiyan M; Karundevi B
Appl Physiol Nutr Metab; 2015 Aug; 40(8):769-81. PubMed ID: 26201855
[TBL] [Abstract][Full Text] [Related]
33. Ginsenoside Rb3 strengthens the hypoglycemic effect through AMPK for inhibition of hepatic gluconeogenesis.
Meng F; Su X; Li W; Zheng Y
Exp Ther Med; 2017 May; 13(5):2551-2557. PubMed ID: 28565878
[TBL] [Abstract][Full Text] [Related]
34. Entada phaseoloides extract suppresses hepatic gluconeogenesis via activation of the AMPK signaling pathway.
Zheng T; Hao X; Wang Q; Chen L; Jin S; Bian F
J Ethnopharmacol; 2016 Dec; 193():691-699. PubMed ID: 27742409
[TBL] [Abstract][Full Text] [Related]
35. Itraconazole attenuates hepatic gluconeogenesis and promotes glucose uptake by regulating AMPK pathway.
Na RS; Ma C; Liu QR; Wu LM; Zheng XL; Liu ZW
Exp Ther Med; 2018 Feb; 15(2):2165-2171. PubMed ID: 29434820
[TBL] [Abstract][Full Text] [Related]
36. PPP1R3C mediates metformin-inhibited hepatic gluconeogenesis.
Ji X; Wang S; Tang H; Zhang Y; Zhou F; Zhang L; Zhu Q; Zhu K; Liu Q; Liu Y; Wang X; Zhou L
Metabolism; 2019 Sep; 98():62-75. PubMed ID: 31181215
[TBL] [Abstract][Full Text] [Related]
37. Guava leaf inhibits hepatic gluconeogenesis and increases glycogen synthesis via AMPK/ACC signaling pathways in streptozotocin-induced diabetic rats.
Vinayagam R; Jayachandran M; Chung SSM; Xu B
Biomed Pharmacother; 2018 Jul; 103():1012-1017. PubMed ID: 29710658
[TBL] [Abstract][Full Text] [Related]
38. Current understanding on pathogenesis and effective treatment of glycogen storage disease type Ib with empagliflozin: new insights coming from diabetes for its potential implications in other metabolic disorders.
Maiorana A; Tagliaferri F; Dionisi-Vici C
Front Endocrinol (Lausanne); 2023; 14():1145111. PubMed ID: 37152929
[TBL] [Abstract][Full Text] [Related]
39. Saponarin activates AMPK in a calcium-dependent manner and suppresses gluconeogenesis and increases glucose uptake via phosphorylation of CRTC2 and HDAC5.
Seo WD; Lee JH; Jia Y; Wu C; Lee SJ
Bioorg Med Chem Lett; 2015 Nov; 25(22):5237-42. PubMed ID: 26471090
[TBL] [Abstract][Full Text] [Related]
40. Water Extract of
Li T; Chang R; Zhang H; Du M; Mao X
Front Nutr; 2020; 7():161. PubMed ID: 33043040
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
